139 related articles for article (PubMed ID: 9690660)
1. Granin-A, parathyroid hormone-related protein, and calcitonin gene products in neuroendocrine prostate cancer.
Deftos LJ
Prostate Suppl; 1998; 8():23-31. PubMed ID: 9690660
[TBL] [Abstract][Full Text] [Related]
2. Granins and prostate cancer.
Deftos LJ; Abrahamsson PA
Urology; 1998 May; 51(5A Suppl):141-5. PubMed ID: 9610570
[TBL] [Abstract][Full Text] [Related]
3. Parathyroid hormone-related protein, chromogranin A, and calcitonin gene products in the neuroendocrine skin carcinoma cell lines MKL1 and MKL2.
Martin EM; Gould VE; Hoog A; Rosen ST; Radosevich JA; Deftos LJ
Bone Miner; 1991 Aug; 14(2):113-20. PubMed ID: 1717086
[TBL] [Abstract][Full Text] [Related]
4. Evaluation and clinical value of neuroendocrine differentiation in human prostatic tumors.
Cussenot O; Villette JM; Cochand-Priollet B; Berthon P
Prostate Suppl; 1998; 8():43-51. PubMed ID: 9690663
[TBL] [Abstract][Full Text] [Related]
5. Immunoassay and immunohistology studies of chromogranin A as a neuroendocrine marker in patients with carcinoma of the prostate.
Deftos LJ; Nakada S; Burton DW; di Sant'Agnese PA; Cockett AT; Abrahamsson PA
Urology; 1996 Jul; 48(1):58-62. PubMed ID: 8693652
[TBL] [Abstract][Full Text] [Related]
6. Characterization of neuroendocrine differentiation in human benign prostate and prostatic adenocarcinoma.
Aprikian AG; Cordon-Cardo C; Fair WR; Reuter VE
Cancer; 1993 Jun; 71(12):3952-65. PubMed ID: 7685237
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the cell-specific expression of parathyroid hormone-related protein in normal and neoplastic prostate tissue.
Wu G; Iwamura M; di Sant'Agnese PA; Deftos LJ; Cockett AT; Gershagen S
Urology; 1998 May; 51(5A Suppl):110-20. PubMed ID: 9610565
[TBL] [Abstract][Full Text] [Related]
8. Presence of chromogranins and regulation of their synthesis and processing in a neuroendocrine prostate tumor cell line.
Ischia R; Culig Z; Eder U; Bartsch G; Winkler H; Fischer-Colbrie R; Klocker H
Prostate Suppl; 1998; 8():80-7. PubMed ID: 9690667
[TBL] [Abstract][Full Text] [Related]
9. Different profiles of neuroendocrine cell differentiation evolve in the PC-310 human prostate cancer model during long-term androgen deprivation.
Jongsma J; Oomen MH; Noordzij MA; Van Weerden WM; Martens GJ; van der Kwast TH; Schröder FH; van Steenbrugge GJ
Prostate; 2002 Mar; 50(4):203-15. PubMed ID: 11870798
[TBL] [Abstract][Full Text] [Related]
10. Parathyroid hormone-related protein is expressed by prostatic neuroendocrine cells.
Iwamura M; Wu G; Abrahamsson PA; di Sant'Agnese PA; Cockett AT; Deftos LJ
Urology; 1994 May; 43(5):667-74. PubMed ID: 8165767
[TBL] [Abstract][Full Text] [Related]
11. [Role of neuroendocrine cells in prostate cancer progression].
Sciarra A; Innocenzi M; Ravaziol M; Minisola F; Alfarone A; Cattarino S; Panebianco V; Buonocore V; Gentile V; Di Silverio F
Urologia; 2011; 78(2):126-31. PubMed ID: 21574145
[TBL] [Abstract][Full Text] [Related]
12. Modulation of neuroendocrine differentiation in prostate cancer by interleukin-1 and -2.
Diaz M; Abdul M; Hoosein N
Prostate Suppl; 1998; 8():32-6. PubMed ID: 9690661
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of neuroendocrine expression in lymph node-positive prostate cancer.
Quek ML; Daneshmand S; Rodrigo S; Cai J; Dorff TB; Groshen S; Skinner DG; Lieskovsky G; Pinski J
Urology; 2006 Jun; 67(6):1247-52. PubMed ID: 16697447
[TBL] [Abstract][Full Text] [Related]
14. Production of calcitonin gene related peptide, calcitonin and PTH-related protein by a prostatic adenocarcinoma.
Shulkes A; Fletcher DR; Rubinstein C; Ebeling PR; Martin TJ
Clin Endocrinol (Oxf); 1991 May; 34(5):387-93. PubMed ID: 2060148
[TBL] [Abstract][Full Text] [Related]
15. The neuroendocrine phenotype in prostate cancer: basic and clinical aspects.
Mosca A; Berruti A; Russo L; Torta M; Dogliotti L
J Endocrinol Invest; 2005; 28(11 Suppl International):141-5. PubMed ID: 16625864
[TBL] [Abstract][Full Text] [Related]
16. Neuroendocrine differentiation in prostatic carcinomas. A retrospective autopsy study.
Turbat-Herrera EA; Herrera GA; Gore I; Lott RL; Grizzle WE; Bonnin JM
Arch Pathol Lab Med; 1988 Nov; 112(11):1100-5. PubMed ID: 2460064
[TBL] [Abstract][Full Text] [Related]
17. Potential clinical value of circulating chromogranin A in patients with prostate carcinoma.
Berruti A; Dogliotti L; Mosca A; Gorzegno G; Bollito E; Mari M; Tarabuzzi R; Poggio M; Torta M; Fontana D; Angeli A
Ann Oncol; 2001; 12 Suppl 2():S153-7. PubMed ID: 11762344
[TBL] [Abstract][Full Text] [Related]
18. Neuroendocrine differentiation in prostate cancer.
Cerović SJ; Brajusković GR; Vukotić Maletić VD; Mićić SR
Vojnosanit Pregl; 2004; 61(5):513-8. PubMed ID: 15551804
[TBL] [Abstract][Full Text] [Related]
19. Androgen deprivation of the PC-310 [correction of prohormone convertase-310] human prostate cancer model system induces neuroendocrine differentiation.
Jongsma J; Oomen MH; Noordzij MA; Van Weerden WM; Martens GJ; van der Kwast TH; Schröder FH; van Steenbrugge GJ
Cancer Res; 2000 Feb; 60(3):741-8. PubMed ID: 10676662
[TBL] [Abstract][Full Text] [Related]
20. Parathyroid hormone-related protein: a potential autocrine growth regulator in human prostate cancer cell lines.
Iwamura M; Abrahamsson PA; Foss KA; Wu G; Cockett AT; Deftos LJ
Urology; 1994 May; 43(5):675-9. PubMed ID: 8165768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
